CURATOLO, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 66.666
AS - Asia 6.581
EU - Europa 5.683
SA - Sud America 1.121
Continente sconosciuto - Info sul continente non disponibili 583
AF - Africa 108
OC - Oceania 37
Totale 80.779
Nazione #
US - Stati Uniti d'America 66.400
SG - Singapore 3.068
CN - Cina 1.132
BR - Brasile 895
IT - Italia 856
UA - Ucraina 845
DE - Germania 827
RU - Federazione Russa 752
HK - Hong Kong 664
IE - Irlanda 648
VN - Vietnam 546
FR - Francia 485
GB - Regno Unito 339
KR - Corea 291
FI - Finlandia 229
JP - Giappone 207
PL - Polonia 182
BD - Bangladesh 157
SE - Svezia 150
NL - Olanda 137
CA - Canada 130
IN - India 121
AR - Argentina 81
MX - Messico 58
ID - Indonesia 53
IQ - Iraq 50
TR - Turchia 46
ES - Italia 41
AT - Austria 40
TW - Taiwan 38
EC - Ecuador 35
AU - Australia 34
ZA - Sudafrica 31
CO - Colombia 30
BE - Belgio 29
CZ - Repubblica Ceca 25
MY - Malesia 25
PH - Filippine 23
VE - Venezuela 23
CL - Cile 20
MA - Marocco 20
UZ - Uzbekistan 19
PK - Pakistan 18
SA - Arabia Saudita 17
TH - Thailandia 17
JM - Giamaica 15
KE - Kenya 15
RO - Romania 14
DZ - Algeria 13
LT - Lituania 12
PE - Perù 12
CR - Costa Rica 11
GR - Grecia 11
IR - Iran 10
NP - Nepal 10
PT - Portogallo 10
UY - Uruguay 10
CH - Svizzera 9
EG - Egitto 9
KG - Kirghizistan 9
NI - Nicaragua 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
KZ - Kazakistan 8
HU - Ungheria 7
IL - Israele 7
JO - Giordania 7
SV - El Salvador 7
EU - Europa 6
HN - Honduras 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
LB - Libano 5
BB - Barbados 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
ET - Etiopia 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
FO - Isole Faroe 2
HT - Haiti 2
KW - Kuwait 2
LK - Sri Lanka 2
MM - Myanmar 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
Totale 80.179
Città #
Woodbridge 18.905
Wilmington 17.229
Houston 14.271
Fairfield 2.321
Singapore 1.702
Ann Arbor 1.506
Ashburn 1.239
Seattle 895
San Jose 837
Chandler 830
Cambridge 822
Jacksonville 732
Hong Kong 644
Dublin 610
Medford 483
Dearborn 434
Beijing 433
Council Bluffs 361
Santa Clara 356
New York 265
Lawrence 227
Los Angeles 223
The Dalles 214
Rome 205
Ho Chi Minh City 169
Kraków 155
Tokyo 147
Lauterbourg 145
Buffalo 134
Hanoi 131
Moscow 130
Dallas 125
San Diego 110
Chicago 99
Menlo Park 94
Norwalk 94
Mülheim 85
Milan 80
Munich 71
São Paulo 68
London 61
Nuremberg 49
Redwood City 47
Redondo Beach 40
Zhengzhou 38
University Park 37
Boardman 36
Helsinki 34
Taipei 34
Verona 34
Jakarta 33
Frankfurt am Main 32
Toronto 32
Phoenix 30
Chennai 28
Haiphong 28
Montreal 28
Rio de Janeiro 28
Salt Lake City 28
Shanghai 28
Falls Church 27
North Bergen 27
Orem 26
Seoul 26
Belo Horizonte 25
Mountain View 25
Nanjing 25
San Francisco 25
Saint Petersburg 24
Warsaw 24
Brno 23
Brooklyn 23
Denver 23
Hyderabad 23
Da Nang 22
Guangzhou 21
Brussels 20
Amsterdam 19
Kunming 19
Lappeenranta 19
Nijmegen 19
San Mateo 19
Brasília 18
Columbus 18
Detroit 18
Poplar 18
Stockholm 18
Vienna 18
Atlanta 17
Mexico City 17
Naples 17
Charlotte 16
Curitiba 16
Dhaka 16
Hefei 15
Kuala Lumpur 15
Mumbai 15
Johannesburg 14
Miami 14
St Louis 14
Totale 69.084
Nome #
Current role of perampanel in pediatric epilepsy 543
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 506
Are caesarean sections, induced labor and oxytocin regulation linked to Autism Spectrum Disorders? 504
Oxygen exchange and energy metabolism in erythrocytes of Rett syndrome and their relationships with respiratory alterations 499
Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study 498
Human endogenous retroviruses and ADHD 494
Association study of autistic disorder and chromosome 16p 485
Association between presenilin-1 -48C/T polymorphism and Down's syndrome 481
Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options. 479
ADHD and epilepsy in children with Tourette syndrome: a triple comorbidity? 473
Adhd and human endogenous retroviruses 472
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 471
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. 471
Tourette syndrome and comorbid ADHD: causes and consequences 462
Comorbidity of ADHD and dyslexia. 461
Two epileptic syndromes, one brain: Childhood absence epilepsy and benign childhood epilepsy with centrotemporal spikes 454
Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. 453
Reduction in Retinal Nerve Fiber Layer Thickness in Young Adults with Autism Spectrum Disorders 453
Association of adenosine deaminase polymorphism with mild mental retardation 452
mTOR Inhibitors in Tuberous Sclerosis Complex. 452
The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families 452
Can biological components predict short-term evolution in Autism Spectrum Disorders? A proof-of-concept study 452
Interstitial deletion of a proximal 3p: a clinically recognisable syndrome 449
Impairment in flexible regulation of speed and accuracy in children with ADHD 449
Website and Headache: Assessment of The Information Quality using the DISCERN Tool 447
Convulsive disorder and the genetics of signal transduction; a study of a low molecular weight protein tyrosine phosphatase in a pediatric sample 446
Current role of melatonin in pediatric neurology: Clinical recommendations 446
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 445
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 441
Long term clinical course of Tourette syndrome. 437
Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism 436
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 436
Lack of association between IDE genetic variability and Down's syndrome 434
Cortical maldevelopment in congenital cytomegalovirus infection transmitted by a woman with preexisting immunity. 434
MTHFR C677T and A1298C polymorphisms and cerebral stroke in two twin gestations 434
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 434
Efficacy of intensive versus nonintensive physiotherapy in children with cerebral palsy: a meta-analysis. 433
Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy 432
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 431
Optical coherence tomography and infrared images of astrocytic hamartomas not revealed by funduscopy in tuberous sclerosis complex 428
Conceptual and methodological challenges for neuroimaging studies of autistic spectrum disorders. 428
Cluster analysis of autistic patients based on principal pathogenetic components. 427
Management of epilepsy in tuberous sclerosis complex 427
Epilepsy in tuberous sclerosis complex. 426
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 426
Attention and executive functions profile in drug naive ADHD subtypes 425
Urinary p-cresol is elevated in small children with severe autism spectrum disorder. 425
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 425
Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. 424
De novo mosaic ring chromosome 18 in a child with mental retardation, epilepsy and immunological problems 424
Use of the DISCERN tool for evaluating web searches in childhood epilepsy. 424
The neurobiology of attention deficit/hyperactivity disorder. 423
Medical treatment in children with central nervous system malformations 423
TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients. 423
Candidate gene study of HOXB1 in autism spectrum disorder. 420
Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations. 419
Synapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014. 419
Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)? 419
Refractory absence seizures: An Italian multicenter retrospective study 419
Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial 418
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 417
Syndromic autism: Causes and pathogenetic pathways 415
Methylphenidate-induced visual hallucinations. 414
HERVs expression in autism spectrum disorders 414
Long-term neurological outcome of a sextuplet pregnancy. 414
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 414
Detection of auto-antibodies to DAT in the serum: interactions with DAT genotype and psycho-stimulant therapy for ADHD. 413
Association of Trp53 polymorphic variants at codon 72 with nonsyndromic mental retardation 412
Preterm birth and neurodevelopmental outcome: a review 412
Hypnic headache in children. 412
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. 412
Effectiveness of community-based treatment on clinical outcome in children with autism spectrum disorders: An Italian prospective study. 412
Two-loci ADA haplotypes in autistic disorder 411
Child neurology: role of the International Association. 411
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 410
Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities 409
Recommendations for early diagnosis and intervention in autism spectrum disorders: an Italian-Israeli consensus conference 409
Late-onset epileptic spasms in children with Pallister-Killian syndrome: a report of two new cases and review of the electroclinical aspects. 408
Autism in tuberous sclerosis 407
Benign childhood epilepsy with centrotemporal spikes and the multicomponent model of attention: a matched control study. 407
Early-onset pure absence epilepsy: a distinct epileptic syndrome. 407
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex 407
Altered anandamide degradation in attention-deficit/hyperactivity disorder 406
Epilepsy associated with autism and attention deficit hyperactivity disorder: is there a genetic link? 406
Lack of association between MTHFR C677T and MTHFR A1298C genetic polymorphisms and mental retardation 404
Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome 404
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 404
Attention and executive functions profile in childhood absence epilepsy. 403
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 403
Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: Significant clinical improvement during tamoxifen treatment 402
Neurobehavioral phenotype observed in KBG syndrome caused by ANKRD11 mutations 401
Autism: evidence of association with adenosine deaminase genetic polymorphism 400
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 400
Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry. 400
The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity 400
Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects 399
MRI appearance of Sturge-Weber syndrome in tuberous sclerosis complex: is the neural crest the culprit? 399
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 397
Rufinamide for refractory focal seizures: an open-label, multicenter European study. 396
Introduction. 394
Totale 43.088
Categoria #
all - tutte 187.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.649


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.716 0 0 83 44 40 201 109 80 206 180 175 598
2022/20232.384 267 198 61 233 213 611 244 139 190 12 158 58
2023/2024744 121 20 45 7 58 189 26 19 19 22 52 166
2024/20255.287 146 1.344 680 312 108 339 413 235 406 659 298 347
2025/20267.730 582 382 958 624 781 241 951 938 985 600 431 257
2026/20271.009 495 461 53 0 0 0 0 0 0 0 0 0
Totale 80.779